Dr. Michael Lang is the Global Drug & Device CREA, xTA & Strategy at Boehringer Ingelheim Pharma GmbH & Co. KG, where he leads strategic growth initiatives, drives operational excellence, and champions digital transformation across the organization. With over a decade of experience in innovation and business strategy, he has a proven track record in implementing continuous improvement programs, master data management concepts, and digitalization strategies. Before joining Boehringer Ingelheim in 2021, Dr. Lang held leadership roles in digital business innovation at Schaeffler and product project management at Liebherr Appliances, where he focused on cost optimization, agile development, and digital initiatives.
&nsbp;
